Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers

Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with treatable sexually transmitted infections (STIs) – including chlamydia, gonorrhea, and trichomoniasis – without the health care provider first examining the partner(s).

This document explains what EPT is and why clinicians in California should prescribe it. In-depth references are also provided.

Download PDF

Clinical Practice Alert: Syphilis Screening, Diagnosis, and Treatment

Rates of syphilis have been rising in the US, including in California, which has resulted in a corresponding rise in the rates of congenital syphilis (CS). Fifteen percent of women of childbearing age diagnosed with syphilis are pregnant.

These trends mirror a sharp increase in all stages of syphilis among females, which increased more than 500 percent during the same period. Download the PDF to learn more.

This Clinical Practice Alert includes management of primary, secondary, and latent syphilis. It does not include screening and management of syphilis in people who are pregnant or the diagnosis and treatment of tertiary syphilis.

Download PDF

Long-Acting Injectable PrEP

Resources and updates from the CAPTC’s Long-Acting Injectable PrEP Learning Collaborative to support clinics and navigators.

Includes Clinical and Access and Financing FAQs in English and Español, as well as clinical protocols and other resources.

Visit site

Community Engagement World Café

When policies and programs designed to improve health outcomes are not driven by community interests, concerns, or needs, efforts remain disconnected from the people they intend to serve. Aunsha Hall-Everett engages participants in a deeper discussion about the various examples of community engagement strategies discussed by presenters and how they can be used in their jurisdictions to maximize structural impact.

Watch all recorded videos from our Structural Interventions for HIV Prevention and Care Virtual Institute.

View Video

An aerial view of the downtown Oakland skyline on a clear sunny day.

California STI Treatment Recommendations in Pregnancy

These treatment regimens reflect the U.S. Centers for Disease Control and Prevention (CDC) STI Treatment Guidelines that are specific to pregnant people.

View an ADA-compliant version of this table.

Download PDF

California STI/HIV Screening Recommendations in Pregnancy

Reflecting California HIV/STI screening recommendations for pregnant patients at various pregnancy stages.

View an ADA-compliant version of this document.

Download PDF

PrEP Financing Resources

Resources and updates from the CAPTC’s PrEP Financing Learning Collaborative to support clinics and navigators with PrEP financing questions.

Includes information on California’s PrEP Assistance Program (PrEP-AP), other resources for covering the cost of PrEP, billing resources, and other coverage information for patients and providers.

Visit Site

Opt-Out ED Screening for HIV, HCV, and Syphilis—Dear Colleague Letter from CDPH

March 28, 2022: Emergency departments (EDs) are uniquely positioned to identify people with syphilis, HIV, and hepatitis C who otherwise might remain undiagnosed. The California Department of Public Health (CDPH) recommends that EDs consider implementing routine opt-out testing for syphilis, HIV, and hepatitis C.

Identification and immediate treatment through the ED may have the added benefit of furthering health equity for those disproportionately affected by these infections

Download PDF

Building an Affirming Healthcare System

Andrew Miller defines key terminology used within LGBTQ-affirming healthcare, describes components of an LGBTQ-affirming healthcare system, and discusses how to evaluate a healthcare system for LGBTQ- affirming practices and procedures. Andrew is followed by a special message from Admiral Dr. Rachel Levine.

Watch all recorded videos from our 2022 Medical Mistrust Symposium

View Video

2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement

Updated Clinical Providers’ Supplement accompanying the 2021 PrEP Clinical Practice Guideline.

Updates for 2021 include:

Checklist updated to include Descovy, 2-1-1 Truvada for MSM, and cabotegravir
Added PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) recommendation for HIV prevention in adults
Added information about Descovy and cabotegravir to Patient Information Sheets

Download PDF